GPhA restructuring could head off Teva's departure from trade group
This article was originally published in Scrip
Executive Summary
Teva Pharmaceutical Industries' announcement that it is resigning from the Generic Pharmaceutical Association (GPhA) in June could prompt restructuring and leadership changes at the trade organisation in a bid to hold onto the world's largest generics firm.